The approach could enable 30-minute testing for a heart condition that is newly treatable following recent drug approvals.

NEW YORK – Lex Diagnostics announced Friday that it has submitted its point-of-care molecular diagnostics system along with a test to detect influenza A, influenza B, and COVID-19 to the US Food and ...

NEW YORK – New data published in JAMA Internal Medicine on Friday from MD Anderson Cancer Center researchers found that mail-in self-collection kits for human papillomavirus testing more than doubled ...

Owner Zishan Alvi submitted claims for COVID-19 tests that were either never performed or were performed incorrectly, releasing potentially false negative test results to patients.

NEW YORK – Qiagen announced on Wednesday that it has launched a third-party partnering program for its clinical digital PCR platform and signed an agreement with the program's inaugural partner, South ...

Adding the firm's multi-cancer early detection test to standard-of-care screening demonstrated substantially greater additional cancer detection than in Pathfinder.

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

The firm said in May it was considering the surcharge following disclosure of a $40 million tariff-related headwind for 2025.

The shares are expected to begin trading on June 18 under the ticker symbol CAI, and the offering is expected to close on June 20.

NEW YORK – Canadian researchers have developed a point-of-care molecular blood test to quickly predict which patients in the emergency department or ICU are likely to develop sepsis within 24 hours.

NEW YORK — EDX Medical Group said Monday that it has a signed a memorandum of understanding with UK-based healthcare group Spire Healthcare around diagnostic products and testing services.